Search | VHL Search Portal

1.

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Afdhal, Nezam; Zeuzem, Stefan; Kwo, Paul; Chojkier, Mario; Gitlin, Norman; Puoti, Massimo; Romero-Gomez, Manuel; Zarski, Jean-Pierre; Agarwal, Kosh; Buggisch, Peter; Foster, Graham R; Bräu, Norbert; Buti, Maria; Jacobson, Ira M; Subramanian, G Mani; Ding, Xiao; Mo, Hongmei; Yang, Jenny C; Pang, Phillip S; Symonds, William T; McHutchison, John G; Muir, Andrew J; Mangia, Alessandra; Marcellin, Patrick.

N Engl J Med ; 370(20): 1889-98, 2014 May 15.

Article in English | MEDLINE | ID: mdl-24725239

2.

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

Afdhal, Nezam; Reddy, K Rajender; Nelson, David R; Lawitz, Eric; Gordon, Stuart C; Schiff, Eugene; Nahass, Ronald; Ghalib, Reem; Gitlin, Norman; Herring, Robert; Lalezari, Jacob; Younes, Ziad H; Pockros, Paul J; Di Bisceglie, Adrian M; Arora, Sanjeev; Subramanian, G Mani; Zhu, Yanni; Dvory-Sobol, Hadas; Yang, Jenny C; Pang, Phillip S; Symonds, William T; McHutchison, John G; Muir, Andrew J; Sulkowski, Mark; Kwo, Paul.

N Engl J Med ; 370(16): 1483-93, 2014 Apr 17.

Article in English | MEDLINE | ID: mdl-24725238

3.

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.

Wilder, Julius M; Jeffers, Lennox J; Ravendhran, Natarajan; Shiffman, Mitchell L; Poulos, John; Sulkowski, Mark S; Gitlin, Norman; Workowski, Kimberly; Zhu, Yanni; Yang, Jenny C; Pang, Phillip S; McHutchison, John G; Muir, Andrew J; Howell, Charles; Kowdley, Kris; Afdhal, Nezam; Reddy, K Rajender.

Hepatology ; 63(2): 437-44, 2016 Feb.

Article in English | MEDLINE | ID: mdl-26547499

4.

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.

Kwo, Paul; Gitlin, Norman; Nahass, Ronald; Bernstein, David; Etzkorn, Kyle; Rojter, Sergio; Schiff, Eugene; Davis, Mitchell; Ruane, Peter; Younes, Ziad; Kalmeijer, Ronald; Sinha, Rekha; Peeters, Monika; Lenz, Oliver; Fevery, Bart; De La Rosa, Guy; Scott, Jane; Witek, James.

Hepatology ; 64(2): 370-80, 2016 08.

Article in English | MEDLINE | ID: mdl-26799692

5.

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.

Nelson, David R; Cooper, James N; Lalezari, Jacob P; Lawitz, Eric; Pockros, Paul J; Gitlin, Norman; Freilich, Bradley F; Younes, Ziad H; Harlan, William; Ghalib, Reem; Oguchi, Godson; Thuluvath, Paul J; Ortiz-Lasanta, Grisell; Rabinovitz, Mordechai; Bernstein, David; Bennett, Michael; Hawkins, Trevor; Ravendhran, Natarajan; Sheikh, Aasim M; Varunok, Peter; Kowdley, Kris V; Hennicken, Delphine; McPhee, Fiona; Rana, Khurram; Hughes, Eric A.

Hepatology ; 61(4): 1127-35, 2015 Apr.

Article in English | MEDLINE | ID: mdl-25614962

6.

On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.

Kowdley, Kris V; Nelson, David R; Lalezari, Jacob P; Box, Terry; Gitlin, Norman; Poleynard, Gary; Rabinovitz, Mordechai; Ravendhran, Natarajan; Sheikh, Aasim M; Siddique, Asma; Bhore, Rafia; Noviello, Stephanie; Rana, Khurram.

Liver Int ; 36(11): 1611-1618, 2016 11.

Article in English | MEDLINE | ID: mdl-27188960

7.

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.

Everson, Gregory T; Sims, Karen D; Thuluvath, Paul J; Lawitz, Eric; Hassanein, Tarek; Rodriguez-Torres, Maribel; Desta, Tadesse; Hawkins, Trevor; Levin, James M; Hinestrosa, Federico; Rustgi, Vinod; Schwartz, Howard; Younossi, Zobair; Webster, Lynn; Gitlin, Norman; Eley, Timothy; Huang, Shu-Pang; McPhee, Fiona; Grasela, Dennis M; Gardiner, David F.

Liver Int ; 36(2): 189-97, 2016 Feb.

Article in English | MEDLINE | ID: mdl-26473667

8.

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Lawitz, Eric; Sulkowski, Mark S; Ghalib, Reem; Rodriguez-Torres, Maribel; Younossi, Zobair M; Corregidor, Ana; DeJesus, Edwin; Pearlman, Brian; Rabinovitz, Mordechai; Gitlin, Norman; Lim, Joseph K; Pockros, Paul J; Scott, John D; Fevery, Bart; Lambrecht, Tom; Ouwerkerk-Mahadevan, Sivi; Callewaert, Katleen; Symonds, William T; Picchio, Gaston; Lindsay, Karen L; Beumont, Maria; Jacobson, Ira M.

Lancet ; 384(9956): 1756-65, 2014 Nov 15.

Article in English | MEDLINE | ID: mdl-25078309

9.

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study.

Barritt, A Sidney; Watkins, Stephanie; Gitlin, Norman; Klein, Samuel; Lok, Anna S; Loomba, Rohit; Schoen, Cheryl; Reddy, K Rajender; Trinh, Huy Ngoc; Mospan, Andrea R; Vos, Miriam B; Weiss, L Michael; Cusi, Kenneth; Neuschwander-Tetri, Brent A; Sanyal, Arun J.

Hepatol Commun ; 5(6): 938-946, 2021 Jun.

Article in English | MEDLINE | ID: mdl-34141981

10.

Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients.

Marcellin, Patrick; Gish, Robert G; Gitlin, Norman; Heise, Jamie; Halliman, Deanine G; Chun, Eric; Rodriguez-Torres, Maribel.

J Hepatol ; 52(1): 32-8, 2010 Jan.

Article in English | MEDLINE | ID: mdl-19913323

11.

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.

Hassanein, Tarek; Sims, Karen D; Bennett, Michael; Gitlin, Norman; Lawitz, Eric; Nguyen, Tuan; Webster, Lynn; Younossi, Zobair; Schwartz, Howard; Thuluvath, Paul J; Zhou, Helen; Rege, Bhaskar; McPhee, Fiona; Zhou, Nannan; Wind-Rotolo, Megan; Chung, Ellen; Griffies, Amber; Grasela, Dennis M; Gardiner, David F.

J Hepatol ; 62(5): 1204-6, 2015 May.

Article in English | MEDLINE | ID: mdl-25559328

12.

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.

Bacon, Bruce R; Shiffman, Mitchell L; Mendes, Flavia; Ghalib, Reem; Hassanein, Tarek; Morelli, Giuseppe; Joshi, Shobha; Rothstein, Kenneth; Kwo, Paul; Gitlin, Norman.

Hepatology ; 49(6): 1838-46, 2009 Jun.

Article in English | MEDLINE | ID: mdl-19291790

13.

Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.

Wahl, Peter M; Rodgers, Keith; Schneeweiss, Sebastian; Gage, Brian F; Butler, Javed; Wilmer, Charles; Nash, Marshall; Esper, Gregory; Gitlin, Norman; Osborn, Neal; Short, Louise J; Bohn, Rhonda L.

Pharmacoepidemiol Drug Saf ; 19(6): 596-603, 2010 Jun.

Article in English | MEDLINE | ID: mdl-20140892

14.

Treatment of hepatic encephalopathy with rifaximin: more to think about.

Gitlin, Norman.

Hepatology ; 53(3): 1059; author reply 1059-60, 2011 Mar.

Article in English | MEDLINE | ID: mdl-21294145

15.

Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.

Barritt, A S; Gitlin, Norman; Klein, Samuel; Lok, Anna S; Loomba, Rohit; Malahias, Laura; Powell, Margaret; Vos, Miriam B; Weiss, L Michael; Cusi, Kenneth; Neuschwander-Tetri, Brent A; Sanyal, Arun.

Contemp Clin Trials ; 61: 33-38, 2017 10.

Article in English | MEDLINE | ID: mdl-28735109

16.

Seladelpar (MBX-8025), a selective PPAR-Î´ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.

Jones, David; Boudes, Pol F; Swain, Mark G; Bowlus, Christopher L; Galambos, Michael R; Bacon, Bruce R; Doerffel, Yvonne; Gitlin, Norman; Gordon, Stuart C; Odin, Joseph A; Sheridan, David; Wörns, Markus-Alexander; Clark, Virginia; Corless, Linsey; Hartmann, Heinz; Jonas, Mark E; Kremer, Andreas E; Mells, George F; Buggisch, Peter; Freilich, Bradley L; Levy, Cynthia; Vierling, John M; Bernstein, David E; Hartleb, Marek; Janczewska, Ewa; Rochling, Fedja; Shah, Hemant; Shiffman, Mitchell L; Smith, John H; Choi, Yun-Jung; Steinberg, Alexandra; Varga, Monika; Chera, Harinder; Martin, Robert; McWherter, Charles A; Hirschfield, Gideon M.

Lancet Gastroenterol Hepatol ; 2(10): 716-726, 2017 10.

Article in English | MEDLINE | ID: mdl-28818518

17.

Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.

Gitlin, Norman.

Eur J Gastroenterol Hepatol ; 14(8): 883-5, 2002 Aug.

Article in English | MEDLINE | ID: mdl-12172411

18.

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.

Weaver, Arthur L; Gitlin, Norman.

Arch Intern Med ; 162(19): 2248-9, 2002 Oct 28.

Article in English | MEDLINE | ID: mdl-12390074

19.

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

Zeuzem, Stefan; Diago, Moisés; Gane, Edward; Reddy, K Rajender; Pockros, Paul; Prati, Daniele; Shiffman, Mitchell; Farci, Patrizia; Gitlin, Norman; O'Brien, Christopher B; Lamour, François; Lardelli, Pilar.

Gastroenterology ; 127(6): 1724-32, 2004 Dec.

Article in English | MEDLINE | ID: mdl-15578510

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: